Liang Du

496 citations
17 papers · 409 indexed · h-index 11
Topics
Protease and Inhibitor Mechanisms (6 papers)Virus-based gene therapy research (3 papers)TGF-β signaling in diseases (3 papers)

In The Last Decade

Liang Du

17 papers receiving 398 citations

Peers

Liang Du
Comparison fields: 5 of 61
  • Molecular Biology 152
  • Pulmonary and Respiratory Medicine 111
  • Cancer Research 109
  • Immunology 99
  • Genetics 98
Replace Xiangyuan Pu with:
Xiangyuan Pu China
Sara Sjöberg Sweden
Karen Krchma United States
Taishi Sasaoka Japan
Zexuan Liu China
Roxane M. Pommier France
Erna A Peters Netherlands
Vivek Kaimal United States
Kelly M. Bailey United States
Darrell Wu United States
Liang Du relative to Xiangyuan Pu China Xiangyuan Pu's profile →
Citations per field
00.5×1.5×2.0×
Xiangyuan Pu · 1×
Citations per year

Countries citing papers authored by Liang Du

Since Specialization
Citations

This map shows the geographic impact of Liang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Du more than expected).

Fields of papers citing papers by Liang Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Du. The network helps show where Liang Du may publish in the future.

Co-authorship network of co-authors of Liang Du

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Du. A scholar is included among the top collaborators of Liang Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Du. Liang Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 13
3 5
4 12
5 75
6 6
7 7
8 4
9 50
10 19
11 19
12 38
13 29
14 16
15 84
16 29
17
[Effect of exercise stress on cigarette smoking induced downregulation of BKca and Kv1.5 expression in pulmonary arterial smooth muscle cells of rats].
1

About Liang Du

Liang Du is a scholar working on Cancer Research, Immunology and Allergy and Hematology, having authored 17 papers that have together received 409 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (6 papers), Virus-based gene therapy research (3 papers) and TGF-β signaling in diseases (3 papers). The work is most often cited by research in Cancer Research (109 citations), Immunology and Allergy (33 citations) and Immunology (99 citations). Liang Du has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include David A. Dichek, Jie Hu, Nagadhara Dronadula, Helén L. Dichek, Casilde Sesti, Ranjini Krishnan, Goro Otsuka, Talyn Chu, April Stempien‐Otero and Dylan R. Edwards. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026